← back to search

Paweł K. Mazur

The University of Texas MD Anderson Cancer Center · US
🔎 Find collaborators in Molecular Biology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Epigenetics and DNA Methylation, Lung Cancer Research Studies, RNA modifications and cancer, and Neuroendocrine Tumor Research Advances.
h-index
34
citations
5,626
works
174
NIH funding
primary concept
Biology
email

Recent publications

The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models
Cancer Research 2025cited by 1position: middledoi
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer
Nature 2024cited by 39position: lastdoi
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis
Cell Discovery 2024cited by 18position: middledoi
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Nature Medicine 2024cited by 3position: firstdoi
A Lung Cancer Mouse Model Database
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: middledoi
NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis
Molecular Cell 2021cited by 98position: middledoi
New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting
Gastroenterology 2021cited by 5position: middledoi
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy
Cancer Cell 2020cited by 107position: lastdoi
METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis
Cell 2019cited by 206position: middledoi
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Journal of Clinical Investigation 2019cited by 50position: middledoi
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Nature Medicine 2015cited by 414position: firstdoi
The role of insulin receptor and insulin-like growth factor I receptor in pancreatic ductal adenocarcinoma
Zeitschrift für Gastroenterologie 2013cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Simone Hausmann · The University of Texas MD Anderson Cancer Center5 papers (2019–2024)Or Gozani · Stanford University5 papers (2019–2024)Marcello Caporicci · The University of Texas MD Anderson Cancer Center4 papers (2019–2024)Natasha Flores · The University of Texas MD Anderson Cancer Center4 papers (2019–2024) · 3 papers (2021–2024)Huamin Wang · Chinese Academy of Fishery Sciences2 papers (2019–2020)Ruitu Lyu · University of Illinois Chicago2 papers (2020–2021)Joshua E. Elias · Stanford University2 papers (2019–2020)Ivan Topisirović · McGill University Health Centre2 papers (2019–2024)Michael C. Bassik · Stanford University2 papers (2019–2020)Ignacio I. Wistuba · Disco (Germany)2 papers (2019–2021)Shane Lofgren · Stanford University2 papers (2019–2020)Anirban Maitra · The University of Texas MD Anderson Cancer Center2 papers (2019–2020)Mary E. Fuentes · Temple University2 papers (2019–2020)Julien Sage · Stanford Medicine2 papers (2020–2021) · 2 papers (2019–2024) · 1 papers (2024–2024) · 1 papers (2019–2019)Emily Zahn · University of Virginia1 papers (2024–2024) · 1 papers (2024–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Oncology →